BIONOMICS (BNO) Shares
📊 Bionomics Limited is a biopharmaceutical company with a focus on developing treatments for central nervous system disorders such as anxiety, depression and Alzheimer’s disease. The company operates a high-value portfolio of promising drug candidates from early to mid stages of clinical development.
📊 This portfolio is fed by highly productive drug discovery platforms that include MultiCore, its proprietary chemistry capability.
📊 The company partners with large pharmaceutical companies in order to pass its drugs through the later stages of development and into the market as rapidly as possible. This allows the company to focus on innovative drug discovery to extract as many opportunities from its diverse pipeline.
OVERVIEW OF BIONOMICS
Bionomics Limited has a broad intellectual property portfolio, being the owner on record of 140 issued patents across 4 families and 95 pending patent applications across 37 families filed in Europe, the US and Asia.
The company’s lead drug candidate is BNC210, a novel, orally-administered, first-in-class, negative allosteric modulator of the α7 nicotinic acetylcholine receptor, in development for anxiety, panic, agitation, and post-traumatic stress disorder (PTSD). The company has developed a tablet formulation of BNC210, which has been evaluated in healthy human volunteers.
The company has also entered into collaboration with Merck & Co. (known as MSD outside the United States and Canada) which is continuing the clinical development of its partnered therapeutic candidate for the treatment of cognitive dysfunction in Alzheimer’s disease and other conditions. MSD funds all early-stage and clinical developments of any candidate within the collaboration and is responsible for worldwide commercialization.
Bionomics received US$ 20 million in upfront payments, US$ 10 million upon initiation of Phase 1 clinical trials in February 2017 and is eligible to receive up to US$ 506 million for reaching predefined research and clinical development milestones, plus eventual undisclosed royalties on any product sales.
VISION & VALUES OF BIONOMICS
Bionomics Limited is committed to ensuring that all employees, collaborators and contractors observe the highest standards of ethical behaviour and conduct and follow the principles of its Corporate Social Responsibility.
The company aims to foster an environment of ethical and honest behaviour to protect the interests of its shareholders, employees, business partners and the wider environment within which it operates.
MARKET PERFORMANCE OF BIONOMICS
Bionomics Limited trades on the Australian Securities Exchange (ASX), where investors can buy shares under the stock symbol –BNO.
Data from the company’s 2019 financial analysis shows consolidated revenue for the year to 30 June 2019 was $ 4 million compared to $ 3.9 million at 30 June 2018.
Other income for the year to 30 June 2019 was $ 7.6 million compared to $ 8.5 million at 30 June 2018. This primarily relates to Government Research and Development incentives. The operating loss after tax of the Group for the year to 30 June 2019 was $ 9.7 million compared with the prior year after tax loss of $ 25 million.
The company’s history of delivering a stable performance, coupled with ongoing investment in its portfolio is set to gather returns going forward, providing a rising share price for investors with good long-term growth in dividends, securing a solid buy-in for those who choose to purchase shares today.
Buy BIONOMICS stocks / shares – 📈 A Step by Step Guide how to Buy / Purchase BIONOMICS Stocks or Shares online.
Before buying any stock or share one has to consider a few factors.
STEP 1: PROPER RESEARCH IS ESSENTIAL
Upon deciding you want to buy BIONOMICS Stocks / Shares, it is critical for the serious investor to do proper research into the said company. Its values should align with those of the investor’s current portfolio. An investor needs to familiarise himself with the basics and history of the company, as well as its leadership and performance in the market. Its company reports should also be scrutinized.
Consultation with a brokerage firm can also assist in determining whether investing in a specific company will complement the investor’s current portfolio. The investment “risk ladder”, which identifies asset classes based on their relative riskiness, is another useful tool when determining which company’s stock / share is the best to buy.
STEP 2: CALCULATE THE AMOUNT OF INVESTMENT IN BIONOMICS STOCKS / SHARES
It is important for an investor to monitor his total investment in stock in order to keep his portfolio aligned to his investment strategy. The overall value of his holdings will change with the fluctuation in stock prices, which can throw his portfolio off balance. To determine the amount to invest, multiply the number of shares of each stock by its current market price to determine the total investment in that specific stock. For example, if you own 100 shares of a $5 stock, multiply 100 by $5 to get $500.
STEP 3: DECIDE ON THE STOCK / SHARE ORDER TYPE
Investors can choose from a market order, a limit order, a stop order (also referred to as a stop-loss order) or a buy/sell stop order. It is important to familiarise yourself with each type’s pros and cons before deciding which one will suit your current stock profile best. An investor should be guided in this choice by his investment objective.
STEP 4: OPEN A BROKERAGE ACCOUNT
A brokerage account – also known as taxable investment account – is similar to a retirement account, but more flexible. Where a retirement account has limitations on the amount of money that can be contributed annually, and restrictions on when funds can be withdrawn, a brokerage account is more flexible. The latter has no income or contribution limit and the investor can withdraw his money at any given time. This flexibility, together with its potential investment gains, makes a brokerage account more attractive to serious investors. Brokerage accounts are ideal for goals or savings that are further than five years away, but closer than retirement. It can also supplement an investor’s emergency savings.
STEP 5: COMMIT AND PURCHASE BIONOMICS STOCKS / SHARES
Lastly, commit to the stock. Pro Tip: Monitor the value of your stock to ensure you have a growing stock value and dividend pay-out. Regularly check the share price online to ensure your investment delivers a positive return on investment. You are now a proud owner of BIONOMICS stocks / shares.
5 Questions to ask yourself before purchasing any stocks or shares.
- Is it the best time to buy this stock / share?
- Should I buy BIONOMICS stocks / shares in the current economic climate?
- Can I afford to buy this stock / share?
- What is the forecast of the stock / share growth?
- What is the current price per earning ration on the stock / share?